The surgical aspects of the totally implantable hepatic artery infusion pump

Archives of Surgery

Volumn 136, Issue 3, 2001, Pages 348-352

  Kemeny, M Margaret ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN TC 99M; ANTINEOPLASTIC AGENT; FLUORESCEIN; FREON;

CANCER CHEMOTHERAPY; CHOLECYSTECTOMY; COLORECTAL CANCER; CONTINUOUS INFUSION; DUODENITIS; GASTRITIS; HEPATIC ARTERY; HUMAN; INFUSION PUMP; LIVER ARTERIOGRAPHY; LIVER METASTASIS; LIVER RESECTION; PRIORITY JOURNAL; REVIEW; SCLEROSIS; SURGICAL TECHNIQUE;

EID: 0035092351     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.136.3.348     Document Type: Review

References (12)

1. Balch CM, Urist MM, McGregor ML. Continuous regional chemotherapy for metastatic colorectal cancer using a totally implantable infusion pump. Am J Surg. 1983;145:285-290.
2. Niederhuber JE, Ensminger W, Gyves J, et al. Regional chemotherapy of colorectal cancer metastatic to the liver. Cancer. 1984;53:1336-1343.
3. Kemeny MM. Goldberg DA, Browning S, Metter GE, Miner PJ, Terest JJ. Experience with continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries: a prospective randomized study. Cancer. 1985;55:1265-1270.
4. Hohn D, Stagg R, Friedman M, et al. A randomized trial of continuous intravenous versus hepatic inlraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group Trial. J Clin Oncol. 1989;7:1646-1654.
5. Kemeny N, Daly J, Reichman B, et al. Intrahepatic or systemic infusion of fluoroxyuridine in patients with liver metastases from colorectal carcinoma. Ann Intern Med. 1987;107:459-465.
6. Rougier P, Laplance A, Huguier M, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol. 1992;10:1112-1118.
7. Allen-Mersh TG, Earlam S, Fordy C, et al. Quality of life and survival with continuous hepatic artery floxuridine infusion for colorectal liver metastases. Lancet. 1994;344:1255-1260.
8. Meta-Analysis Group in Cancer. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst. 1996;88:252-258.
9. Kemeny N, Seiter K, Niedzwiecki D, et al. A randomized trial of intrahepatic infusion of fluorodeoxyuridine (FUDR) with dexamethasone versus FUDR alone in the treatment of metastatic colorectal cancer. Cancer. 1992;69:327-334.
10. Kemeny N, Conti J, Cohen A, et al. A phase II study of hepatic arterial FUDR, Leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma. J Clin Oncol. 1994;12:2288-2295.
11. Kemeny MM, Hogan JM, Goldberg DA, et al. Continuous hepatic artery infusion with an implantable pump: problems with hepatic artery anomalies. Surgery. 1986;99:501-504.
12. Kemeny MM, Brennan M. The surgical complications of chemotherapy in the cancer patient. Current Prob Surg. 1987;24:609-675.